Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years - Concepedia

Concepedia

Publication | Open Access

Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

DOI Full Paper Access

115

Citations

21

References

2016

Year

Thomas Danne, Torben Biester, Kerstin Kapitzke, Sanja Hald Jacobsen, Lisbeth V. Jacobsen, Kristin C. Carlsson Petri, Paula M. Hale, Olga Kordonouri

The Journal of Pediatrics

Abstract

ClinicalTrials.gov: NCT01789086.

References

	Year	Citations

Page 1